CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...
Phase 3
Teaneck, New Jersey, United States of America and 152 other locations
The main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID...
Phase 3
Jersey City, New Jersey, United States and 19 other locations
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
New York, New York, United States and 144 other locations
This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...
Phase 4
Staten Island, New York, United States and 98 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
New York, New York, United States and 28 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
New York, New York, United States and 224 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
The Bronx, New York, United States and 257 other locations
study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...
Phase 3
New York, New York, United States and 75 other locations
The purpose of this study is to learn about the safety and effects of the vaccine (called COMIRNATY) for the potential prevention of COVID-19...
Phase 4
New York, New York, United States and 17 other locations
the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...
Phase 4
Jersey City, New Jersey, United States and 150 other locations
Clinical trials
Research sites
Resources
Legal